Harvard Bioscience (HBIO) Other financing activities (2013 - 2026)
Harvard Bioscience (HBIO) reported Other financing activities of $30000.0 for Q1 2026, down 76.74% year-over-year from $129000.0 in Q1 2025, and down 47.37% quarter-over-quarter from $57000.0 in Q4 2025.
Harvard Bioscience (HBIO) Other financing activities (2013 - 2026) Analysis & Trends
Harvard Bioscience (HBIO) has 11 years of Other financing activities data on file, last reported at $30000.0 in Q1 2026.
- Other financing activities for Q1 2026 came in at $30000.0, down 76.74% year-over-year; the trailing twelve-month figure through Mar 2026 was $111000.0 (down 63.25% YoY), and the FY2025 annual result was $156000.0, down 3.11% from the prior year.
- Other financing activities fell to $30000.0 in Q1 2026 per HBIO's latest filing, from $57000.0 in the prior quarter.
- Over five years, Other financing activities peaked at $461000.0 in Q4 2022 and troughed at -$451000.0 in Q4 2023.
- A 5-year average of $122076.9 and a median of $129000.0 in 2025 frame the typical range for Other financing activities.
- The sharpest annual moves came in 2023 and 2025: Other financing activities sank 197.83% in 2023, then soared 174.47% in 2025.
- A 5-year view of Other financing activities shows it stood at $461000.0 in 2022, then slumped by 197.83% to -$451000.0 in 2023, then surged by 135.7% to $161000.0 in 2024, then plunged by 64.6% to $57000.0 in 2025, then sank by 47.37% to $30000.0 in 2026.
- Business Quant data shows HBIO's Other financing activities at $30000.0 in Q1 2026, $57000.0 in Q4 2025, and $24000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Harvard Bioscience | 26.17 Mn | 19.07 Mn | 12.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30,000.00 |
| Mar 31, 2026 | 30,000.00 |
| Dec 31, 2025 | 57,000.00 |
| Dec 31, 2025 | 57,000.00 |
| Sep 30, 2025 | 24,000.00 |
| Sep 30, 2025 | 24,000.00 |
| Mar 31, 2025 | 129,000.00 |
| Mar 31, 2025 | 129,000.00 |
| Sep 30, 2024 | 161,000.00 |
| Sep 30, 2024 | 161,000.00 |
| Jun 30, 2024 | 12,000.00 |
| Jun 30, 2024 | 12,000.00 |
| Mar 31, 2024 | 47,000.00 |
| Mar 31, 2024 | 47,000.00 |
| Dec 31, 2023 | -451,000.00 |
| Dec 31, 2023 | -451,000.00 |
| Jun 30, 2023 | 295,000.00 |
| Jun 30, 2023 | 295,000.00 |
| Mar 31, 2023 | 156,000.00 |
| Mar 31, 2023 | 156,000.00 |